Pegylated interferon and ribavirin treatment for chronic hepatitis C deteriorates subclinical markers of vascular function.
Georgiopoulos G, Alexopoulou A, Pouriki S, Vasilieva L, Laina A, Bampatsias D, Mani I, Kontogiannis C, Tousoulis D, Stamatelopoulos K, Dourakis SP.
Georgiopoulos G, et al. Among authors: alexopoulou a.
Hellenic J Cardiol. 2019 Mar-Apr;60(2):143-145. doi: 10.1016/j.hjc.2018.07.001. Epub 2018 Jul 6.
Hellenic J Cardiol. 2019.
PMID: 31146885
Free article.
No abstract available.